150 Strafford Avenue
About Cagent VascularCagent Vascular is leading the way for next generation technology for vessel dilatation. It is the second cardiovascular company formed by co-founders Carol Burns, President & CEO, Peter Schneider, MD, Vascular Surgeon, Chief Medical Officer and Robert Giasolli, VP of Research and Development.
Co-Founder, President & CEO : Carol A. Burns
Co-Founder, CTO and VP of Research and Development: Robert Giasolli
Co-Founder and CMO: Peter Schneider, MD
CMO: Peter Johansson, PE
10 articles with Cagent Vascular
Cagent Vascular Inc., a developer of next generation angioplasty balloons using serration technology, announced the expansion of its product offering to include larger balloons to treat superficial femoral and popliteal arteries in the Above-the-Knee (ATK) segment.
Cagent Vascular Inc. 1 , a developer of next generation angioplasty balloons using proprietary serration technology, announced the investment of $9M by Sectoral Asset Management.
Cagent Vascular Announces FDA 510(k) Clearance for its Serranator Device for the Infrapopliteal Indication and Completion of its PRELUDE-BTK Clinical Trial Enrollment
Cagent Vascular, a developer of serration technology for vessel dilatation in cardiovascular disease interventions, announces FDA 510(k) Clearance of its Serranator® PTA Serration Balloon Catheter for treating below-the-knee (BTK) lesions.
Cagent Vascular, a developer of serration technology for vessel dilatation in cardiovascular disease interventions, announces the initiation of the PRELUDE-BTK Study
Walsh’s Commercial Expertise will Benefit Cagent’s Efforts to Develop Serranator Market
Cagent Vascular Raises $11.87M to Fund the Growth and Expansion of the Serranator Family of Percutaneous Transluminal Angioplasty (PTA) Serration Balloon Catheters
Cagent Vascular®announced the completion of $11.87 million in Series B funding.
Dr. Andrew Holden (Auckland, New Zealand), Principal Investigator, presented 30-day and preliminary 6-month results using the FDA 510(k) cleared Serranator Alto PTA Serration Balloon Catheter at the Leipzig Interventional Course last week.
Cagent Vascular Wins CE Mark for Serranator, a Next Generation Device for Vessel Dilatation in PA...
11/20/2017The Serranator is one of a family of peripheral artery disease technologies which incorporates proprietary Serration Technology to an angioplasty balloon.